Full Robotic Distal Pancreatectomy: Safety and Feasibility Analysis of a Multicenter Cohort of 236 Patients

Sergio Alfieri, Ugo Boggi, Giovanni Butturini, Andrea Pietrabissa, Luca Morelli, Pierluigi Di Sebastiano, Fabio Vistoli, Isacco Damoli, Andrea Peri, Alfonso Lapergola, Claudio Fiorillo, Paolo Panaccio, Luigi Pugliese, Marco Ramera, Nelide De Lio, Gregorio Di Franco, Fausto Rosa, Roberta Menghi, Giovanni Battista Doglietto, Giuseppe Quero

Research output: Contribution to journalArticle

Abstract

Introduction. Despite the widespread use of the robotic technology, only a few studies with small sample sizes report its application to pancreatic diseases treatment. Our aim is to present the results of a multicenter study on the safety and feasibility of robot-assisted distal pancreatectomy (RDP). Materials and Methods. All RDPs for benign, borderline, and malignant diseases performed in 5 referral centers from 2008 to 2016 were included. Perioperative outcomes were evaluated. Results. Two hundred thirty-six patients were included. Spleen preservation was performed in 114 cases (48.3%). Operative time was 277.8 ± 93.6 minutes. Progressive improvement in operative time was observed over the study period. Conversion rate was 6.3%. Morbidity occurred in 102 cases (43.2%), mainly due to grade A fistulas. Reoperation was required in 10 patients. Postoperatively, 2 patients died of sepsis due to a grade C fistula. Hospital readmission was necessary in 11 cases. A R0 resection was always achieved, with a mean number of 16.2 ± 15 harvested lymph nodes. Conclusion. To our knowledge, this is one of the largest RDP series. Safety and feasibility including the low conversion rate, the high spleen preservation rate, the adequate operative time, and the acceptable morbidity and mortality rates confirm the validity of this technique. Appropriate oncological outcomes have been also obtained.

Original languageEnglish
JournalSurgical Innovation
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Pancreatectomy
Robotics
Operative Time
Safety
Fistula
Spleen
Morbidity
Patient Readmission
Pancreatic Diseases
Reoperation
Sample Size
Multicenter Studies
Sepsis
Referral and Consultation
Lymph Nodes
Technology
Mortality
Therapeutics

Keywords

  • hepatobiliary
  • robotic surgery
  • surgical oncology

ASJC Scopus subject areas

  • Surgery

Cite this

Full Robotic Distal Pancreatectomy : Safety and Feasibility Analysis of a Multicenter Cohort of 236 Patients. / Alfieri, Sergio; Boggi, Ugo; Butturini, Giovanni; Pietrabissa, Andrea; Morelli, Luca; Di Sebastiano, Pierluigi; Vistoli, Fabio; Damoli, Isacco; Peri, Andrea; Lapergola, Alfonso; Fiorillo, Claudio; Panaccio, Paolo; Pugliese, Luigi; Ramera, Marco; De Lio, Nelide; Di Franco, Gregorio; Rosa, Fausto; Menghi, Roberta; Doglietto, Giovanni Battista; Quero, Giuseppe.

In: Surgical Innovation, 01.01.2019.

Research output: Contribution to journalArticle

Alfieri, S, Boggi, U, Butturini, G, Pietrabissa, A, Morelli, L, Di Sebastiano, P, Vistoli, F, Damoli, I, Peri, A, Lapergola, A, Fiorillo, C, Panaccio, P, Pugliese, L, Ramera, M, De Lio, N, Di Franco, G, Rosa, F, Menghi, R, Doglietto, GB & Quero, G 2019, 'Full Robotic Distal Pancreatectomy: Safety and Feasibility Analysis of a Multicenter Cohort of 236 Patients', Surgical Innovation. https://doi.org/10.1177/1553350619868112
Alfieri, Sergio ; Boggi, Ugo ; Butturini, Giovanni ; Pietrabissa, Andrea ; Morelli, Luca ; Di Sebastiano, Pierluigi ; Vistoli, Fabio ; Damoli, Isacco ; Peri, Andrea ; Lapergola, Alfonso ; Fiorillo, Claudio ; Panaccio, Paolo ; Pugliese, Luigi ; Ramera, Marco ; De Lio, Nelide ; Di Franco, Gregorio ; Rosa, Fausto ; Menghi, Roberta ; Doglietto, Giovanni Battista ; Quero, Giuseppe. / Full Robotic Distal Pancreatectomy : Safety and Feasibility Analysis of a Multicenter Cohort of 236 Patients. In: Surgical Innovation. 2019.
@article{8f3baecaaeb64b2f978f79e2c979186d,
title = "Full Robotic Distal Pancreatectomy: Safety and Feasibility Analysis of a Multicenter Cohort of 236 Patients",
abstract = "Introduction. Despite the widespread use of the robotic technology, only a few studies with small sample sizes report its application to pancreatic diseases treatment. Our aim is to present the results of a multicenter study on the safety and feasibility of robot-assisted distal pancreatectomy (RDP). Materials and Methods. All RDPs for benign, borderline, and malignant diseases performed in 5 referral centers from 2008 to 2016 were included. Perioperative outcomes were evaluated. Results. Two hundred thirty-six patients were included. Spleen preservation was performed in 114 cases (48.3{\%}). Operative time was 277.8 ± 93.6 minutes. Progressive improvement in operative time was observed over the study period. Conversion rate was 6.3{\%}. Morbidity occurred in 102 cases (43.2{\%}), mainly due to grade A fistulas. Reoperation was required in 10 patients. Postoperatively, 2 patients died of sepsis due to a grade C fistula. Hospital readmission was necessary in 11 cases. A R0 resection was always achieved, with a mean number of 16.2 ± 15 harvested lymph nodes. Conclusion. To our knowledge, this is one of the largest RDP series. Safety and feasibility including the low conversion rate, the high spleen preservation rate, the adequate operative time, and the acceptable morbidity and mortality rates confirm the validity of this technique. Appropriate oncological outcomes have been also obtained.",
keywords = "hepatobiliary, robotic surgery, surgical oncology",
author = "Sergio Alfieri and Ugo Boggi and Giovanni Butturini and Andrea Pietrabissa and Luca Morelli and {Di Sebastiano}, Pierluigi and Fabio Vistoli and Isacco Damoli and Andrea Peri and Alfonso Lapergola and Claudio Fiorillo and Paolo Panaccio and Luigi Pugliese and Marco Ramera and {De Lio}, Nelide and {Di Franco}, Gregorio and Fausto Rosa and Roberta Menghi and Doglietto, {Giovanni Battista} and Giuseppe Quero",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/1553350619868112",
language = "English",
journal = "Surgical Innovation",
issn = "1553-3506",
publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Full Robotic Distal Pancreatectomy

T2 - Safety and Feasibility Analysis of a Multicenter Cohort of 236 Patients

AU - Alfieri, Sergio

AU - Boggi, Ugo

AU - Butturini, Giovanni

AU - Pietrabissa, Andrea

AU - Morelli, Luca

AU - Di Sebastiano, Pierluigi

AU - Vistoli, Fabio

AU - Damoli, Isacco

AU - Peri, Andrea

AU - Lapergola, Alfonso

AU - Fiorillo, Claudio

AU - Panaccio, Paolo

AU - Pugliese, Luigi

AU - Ramera, Marco

AU - De Lio, Nelide

AU - Di Franco, Gregorio

AU - Rosa, Fausto

AU - Menghi, Roberta

AU - Doglietto, Giovanni Battista

AU - Quero, Giuseppe

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction. Despite the widespread use of the robotic technology, only a few studies with small sample sizes report its application to pancreatic diseases treatment. Our aim is to present the results of a multicenter study on the safety and feasibility of robot-assisted distal pancreatectomy (RDP). Materials and Methods. All RDPs for benign, borderline, and malignant diseases performed in 5 referral centers from 2008 to 2016 were included. Perioperative outcomes were evaluated. Results. Two hundred thirty-six patients were included. Spleen preservation was performed in 114 cases (48.3%). Operative time was 277.8 ± 93.6 minutes. Progressive improvement in operative time was observed over the study period. Conversion rate was 6.3%. Morbidity occurred in 102 cases (43.2%), mainly due to grade A fistulas. Reoperation was required in 10 patients. Postoperatively, 2 patients died of sepsis due to a grade C fistula. Hospital readmission was necessary in 11 cases. A R0 resection was always achieved, with a mean number of 16.2 ± 15 harvested lymph nodes. Conclusion. To our knowledge, this is one of the largest RDP series. Safety and feasibility including the low conversion rate, the high spleen preservation rate, the adequate operative time, and the acceptable morbidity and mortality rates confirm the validity of this technique. Appropriate oncological outcomes have been also obtained.

AB - Introduction. Despite the widespread use of the robotic technology, only a few studies with small sample sizes report its application to pancreatic diseases treatment. Our aim is to present the results of a multicenter study on the safety and feasibility of robot-assisted distal pancreatectomy (RDP). Materials and Methods. All RDPs for benign, borderline, and malignant diseases performed in 5 referral centers from 2008 to 2016 were included. Perioperative outcomes were evaluated. Results. Two hundred thirty-six patients were included. Spleen preservation was performed in 114 cases (48.3%). Operative time was 277.8 ± 93.6 minutes. Progressive improvement in operative time was observed over the study period. Conversion rate was 6.3%. Morbidity occurred in 102 cases (43.2%), mainly due to grade A fistulas. Reoperation was required in 10 patients. Postoperatively, 2 patients died of sepsis due to a grade C fistula. Hospital readmission was necessary in 11 cases. A R0 resection was always achieved, with a mean number of 16.2 ± 15 harvested lymph nodes. Conclusion. To our knowledge, this is one of the largest RDP series. Safety and feasibility including the low conversion rate, the high spleen preservation rate, the adequate operative time, and the acceptable morbidity and mortality rates confirm the validity of this technique. Appropriate oncological outcomes have been also obtained.

KW - hepatobiliary

KW - robotic surgery

KW - surgical oncology

UR - http://www.scopus.com/inward/record.url?scp=85070968830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070968830&partnerID=8YFLogxK

U2 - 10.1177/1553350619868112

DO - 10.1177/1553350619868112

M3 - Article

AN - SCOPUS:85070968830

JO - Surgical Innovation

JF - Surgical Innovation

SN - 1553-3506

ER -